BCM
ZYME icon

Bridgeway Capital Management’s Zymeworks ZYME Stock Holding History

Bridgeway Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-766,944
Closed -$9.13M – 1278
2025
Q1 		$9.13M Buy
766,944
+7,291
+1% +$99.4K 0.23% 126
2024
Q4 		$11.1M Buy
759,653
+17,092
+2% +$239K 0.25% 120
2024
Q3 		$9.32M Buy
742,561
+17,018
+2% +$185K 0.2% 152
2024
Q2 		$6.17M Buy
725,543
+22,860
+3% +$203K 0.14% 203
2024
Q1 		$7.39M Buy
702,683
+22,367
+3% +$248K 0.15% 204
2023
Q4 		$7.07M Buy
680,316
+24,661
+4% +$197K 0.15% 210
2023
Q3 		$4.16M Buy
655,655
+90,382
+16% +$667K 0.1% 331
2023
Q2 		$4.88M Buy
+565,273
New +$5.06M 0.12% 285

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Bridgeway Capital Management's ZYME Position: Q2 2025 in Review

Bridgeway Capital Management sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 766,944 shares — an estimated $9.13M sold.

Bridgeway Capital Management first reported a position in ZYME in Q2 2023 and held it in 8 quarters. The position peaked at $11.1M in Q4 2024. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Bridgeway Capital Management reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 766,944 Zymeworks shares in Q2 2025, an estimated $9.13M.
  • Bridgeway Capital Management first reported a position in Zymeworks in Q2 2023 and held it in 8 quarters.
  • Bridgeway Capital Management's Zymeworks position peaked at $11.1M in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.